uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted January 12, 2021

Seller of Cholesterol, Weight Loss Products, and More Warned for Claims

On November 17, 2020, the FDA issued a warning letter to Bonagens following a review of the company's website, which found statements made about the company's products Anti-Aging Supports, Cholesterol & Diabetes Control, Gout Control, Hypertension Control, Liver Supports, Lungs Supports, Vita-V for Men, and Weight Lost to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at